MTOR and gastric cancer: We first investigated the antitumor effects of 2,6-DMBQ on gastric cancer PDX models and the results showed that 2,6-DMBQ significantly reduced gastric tumor growth by inhibiting the mTOR/p70S6K signaling pathway (Fig. 6a, d).